Filter by
 

Publication date

Series/ Type

Series/type

Language

Main subject

Main subject

Keywords

Keywords

Publications database

Displaying 1 - 5 of 5

Initial reports

EMCDDA initial report on the new psychoactive substance 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC)

December 2021

3-MMC is a synthetic cathinone monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2012. Based on potential public health risks, an initial report has been prepared and submitted to the Commission and the Member States, in accordance with...

Initial reports

EMCDDA initial report on the new psychoactive substance 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC)

December 2021

3-CMC is a synthetic cathinone monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2014. Based on potential public health risks, an initial report has been prepared and submitted to the Commission and the Member States, in accordance with...

Initial reports

EMCDDA initial report on the new psychoactive substance 4F-MDMB-BICA

November 2020

Methyl 2-({[1-(4-fluorobutyl)-1H-indol-3-yl]carbonyl}amino)-3,3-dimethylbutanoate (4F-MDMB-BICA) is a synthetic cannabinoid receptor agonist. Similar to other synthetic cannabinoids, it is sold as a ‘legal’ replacement for cannabis. Because of their high potency, synthetic cannabinoids can pose a...

Initial reports

EMCDDA initial report on the new psychoactive substance MDMB-4en-PINACA

November 2020

Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (MDMB-4en-PINACA) is a synthetic cannabinoid receptor agonist. Similar to other synthetic cannabinoids, it is sold as a ‘legal’ replacement for cannabis and controlled synthetic cannabinoids. Because of their high potency...

Initial reports

EMCDDA initial report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene)

April 2020

Isotonitazene is a synthetic opioid analgesic monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2019. Based on potential public health risks, an initial report has been prepared and submitted to the Commission and the Member States, in...
Loading